Diagnosis and Prevention of Metabolic Syndrome in Combination with Chronic Obstructive Lung Disease

The article highlights the diagnosis and prevention of a metabolic syndrome, combined with chronic obstructive pulmonary disease. The questions of the occurrence of metabolic syndrome, the adequacy of the methods that are used to diagnose the metabolic syndrome are described. Urbanization, environmental pollution, tobacco smoking and many other factors have led to an increase in the number of patients with combined cardiovascular and respiratory system diseases, in particular such as chronic obstructive illness and hypertension. The purpose of the study was to substantiate the expediency of using methods of diagnosis of insulin resistance, estimation of the obesity degree, level of blood pressure and lipid spectrum of blood, and the rheological properties of blood in patients with combined cardiovascular and respiratory system pathology. The role of diet therapy, physical exercises, and drug and non-drug measures in the prevention of a metabolic syndrome associated with chronic obstructive pulmonary disease is shown. Results and discussion. The results of studies showed that low-calorie diet, as well as the omega-3 polyunsaturated fatty acids had influence on the course of IHD and the atherosclerosis. Diet therapy should be aimed at reducing the total caloric content by 20%, but not less than 1200 kcal / day. It is recommended to balance the diet on the main components: proteins – 15%, fats – 30%, carbohydrates – 55-60% of the total. Compliance of the diet should be combined with an increase in physical activity, which plays an important role in reducing the weight of the body, and in maintaining it at an optimal level. The use of pharmacological measures to prevent complications in patients with metabolic syndrome, combined with chronic obstructive pulmonary disease, requires a number of provisions: positive effect or absence of negative influence on the sensitivity of tissues to insulin, glucose, lipid blood spectrum, systemic fibrinolysis, blood pressure level, rheological blood properties. The results of treatment in patients with chronic obstructive pulmonary disease depended on the use of antibiotics, bronchodilators, ambroxol and systemic enzymotherapy. In chronic obstructive pulmonary disease combined with hypertension, special attention was paid to bronchodilators and speleotherapy. Conclusions. Particular importance in the prevention of a metabolic syndrome, combined with chronic obstructive pulmonary disease, acquires the systematic reporting of information on this problem to the population. Primary health care workers should have ongoing preventive work both in healthy patients and in patients with obesity. Mass media, voluntary associations, and food industry workers should and can play a significant role in this.